It is evolutionarily certain that we will have more outbreaks, more pandemics, and frankly, they could be significantly worse ...

The crises at the heart of the government shutdown fight in Washington were coming to a head Saturday as the federal food assistance ...

Two federal judges ruled nearly simultaneously on Friday that President Trump’s administration must to continue to fund SNAP ...

NIH-led research on structural racism was published Friday, even as the Trump administration has cancelled and discredited ...

Health care has become a central issue in this year’s elections, a sign of parties' midterm strategies to come.

Dozens of scientists are considering leaving the Center for Biologics Evaluation and Research, where Prasad serves as ...

Merck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially ...

A month’s supply of Miebo requires $800 and a prescription in the U.S. In Europe, it’s over-the-counter and $20.

A feud between the FDA's Vinay Prasad and his staff is threatening the future of the center that regulates vaccines, ...

Moderna’s market value has fallen by more than 90% — $185 billion, or a full Sony — from its 2021 peak to around $10 billion ...

A bidding war between Novo Nordisk and Pfizer has broken into the open for Metsera, which focuses on developing drugs to ...

A Thursday Senate hearing for President Trump's surgeon general pick, Casey Means, has been postponed because she went into ...